| Normal (n = 50) | Overweight (n = 44) | P value | |
|---|---|---|---|
| Age, yr | 51.69 (47.75–60.20) | 60.11 ± 9.48 | 0.006 |
| Female | 34 (68%) | 25 (56.8%) | 0.263 |
| BMI, kg/m2 | 22.18 (20.56–23.32) | 25.54 (25.06–27.18) | <0.001 |
| W/H ratio | 0.86 ± 0.59 | 0.89 (0.87–0.93) | 0.005 |
| Hb, g/liter | 137.50 (131.75–151.00) | 137.09 ± 18.38 | 0.710 |
| HbA1C, % | 5.20 (4.95–5.40) | 5.25 ± 0.44 | 0.141 |
| I0, mIU/liter | 6.28 ± 3.15 | 7.12 (5.34–9.40) | 0.079 |
| I30, mIU/liter | 50.10 (30.28–76.71) | 56.50 (39.00–82.21) | 0.168 |
| I120, mIU/liter | 37.50 (18.77–58.81) | 47.22 ± 29.54 | 0.386 |
| FPG, mM | 4.65 (4.40–4.90) | 4.75 ± 0.38 | 0.185 |
| G30, mM | 7.95 (6.67–8.60) | 8.83 ± 2.06 | 0.011 |
| G120, mM | 5.47 ± 1.07 | 5.67 ± 1.04 | 0.356 |
| TG, mM | 1.05 (0.70–1.50) | 1.40 (1.12–2.07) | 0.001 |
| TC, mM | 4.68 ± 0.92 | 4.86 ± 0.82 | 0.331 |
| HDL-C, mM | 1.60 (1.30–1.90) | 1.40 (1.20–1.50) | 0.003 |
| LDL-C, mM | 2.72 ± 0.64 | 2.87 ± 0.73 | 0.244 |
| ALT, U/liter | 20.00 (16.00–27.50) | 24.00 (17.25–32.00) | 0.187 |
| AST, U/liter | 22.00 (19.75–26.25) | 26.95 ± 8.58 | 0.026 |
| Normal ( | Overweight ( | P value | |
|---|---|---|---|
| Age, yr | 51.69 (47.75–60.20) | 60.11 ± 9.48 | 0.006 |
| Female | 34 (68%) | 25 (56.8%) | 0.263 |
| BMI, kg/m2 | 22.18 (20.56–23.32) | 25.54 (25.06–27.18) | <0.001 |
| W/H ratio | 0.86 ± 0.59 | 0.89 (0.87–0.93) | 0.005 |
| Hb, g/liter | 137.50 (131.75–151.00) | 137.09 ± 18.38 | 0.710 |
| HbA1C, % | 5.20 (4.95–5.40) | 5.25 ± 0.44 | 0.141 |
| I0, mIU/liter | 6.28 ± 3.15 | 7.12 (5.34–9.40) | 0.079 |
| I30, mIU/liter | 50.10 (30.28–76.71) | 56.50 (39.00–82.21) | 0.168 |
| I120, mIU/liter | 37.50 (18.77–58.81) | 47.22 ± 29.54 | 0.386 |
| FPG, mM | 4.65 (4.40–4.90) | 4.75 ± 0.38 | 0.185 |
| G30, mM | 7.95 (6.67–8.60) | 8.83 ± 2.06 | 0.011 |
| G120, mM | 5.47 ± 1.07 | 5.67 ± 1.04 | 0.356 |
| TG, mM | 1.05 (0.70–1.50) | 1.40 (1.12–2.07) | 0.001 |
| TC, mM | 4.68 ± 0.92 | 4.86 ± 0.82 | 0.331 |
| HDL-C, mM | 1.60 (1.30–1.90) | 1.40 (1.20–1.50) | 0.003 |
| LDL-C, mM | 2.72 ± 0.64 | 2.87 ± 0.73 | 0.244 |
| ALT, U/liter | 20.00 (16.00–27.50) | 24.00 (17.25–32.00) | 0.187 |
| AST, U/liter | 22.00 (19.75–26.25) | 26.95 ± 8.58 | 0.026 |
Kolmogorov-Smirnov test was used to test continuous variables for normal distribution. Data are mean ± SD, median (interquartile range), or number (%). Continuous data with normal distribution were analyzed by two-tailed Student t test. Nonnormally distributed continuous data were analyzed by Mann–Whitney U test. Categorical data are shown as frequency (%) and were analyzed by χ2 test. ALT, alanine aminotransferase; AST, aspartate aminotransferase; FPG, fasting plasma glucose; Hb, hemoglobin; HbA1C, glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein–cholesterol; mIU, milli–international units; TC, total cholesterol; TG, triglycerides; W/H, waist-to-hip ratio; I0, blood insulin level after over night fasting; I30 and I120, blood insulin level at 30 or 120 min point after oral glucose tolerance test; G30 and G120, blood insulin level at 30 or 120 min point after oral glucose tolerance test.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.